You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. STTR Phase I: Energy Harvesting Systems with Ultra High Energy and Power Densities from Ocean Waves and Currents for Green Energy Generation

    SBC: NASCENT DEVICES INC.            Topic: NM

    This Small Business Technology Transfer Phase I project proposes to develop an energy harvesting system from ocean waves and currents utilizing the high energy density and high strain density achieved by recent advances in the development of ionic nano-composites. With the growing need for clean and renewable energy, this topic is of interest to the energy industry and general public. The massive ...

    STTR Phase I 2014 National Science Foundation
  2. STTR Phase I: Advanced Hybrid Piezoelectric Energy Harvester

    SBC: POLYK TECHNOLOGIES LLC            Topic: EI

    This Small Business Technology Transfer Research (STTR) Phase I will develop advanced hybrid energy harvester to provide power for wireless sensor network systems. Although piezoelectric energy harvesters have found broad applications, their power density and mechanical-electrical conversion efficiency are still low, with values at microwatts to milliwatt and

    STTR Phase I 2014 National Science Foundation
  3. STTR Phase I: Development of Bio-compatible and Bio-safe Cell Sorters

    SBC: Ascent Bio-Nano Technologies Inc            Topic: BC

    This Small Business Technology Transfer (STTR) Phase I project will demonstrate the feasibility of microfluidic-based, bio-compatible, bio-safe, fluorescence-activated cell sorters. Cell sorters are powerful, high-throughput, single-cell characterization and purification tools that are vital for labs in fields such as molecular biology, pathology, plant biology, stem cell biology, and medical diag ...

    STTR Phase I 2014 National Science Foundation
  4. STTR Phase I: Rapid and Efficient Scene Modeling for Law Enforcement and Disaster Response

    SBC: NEAR EARTH AUTONOMY, INC            Topic: EI

    This Small Business Technology Transfer Research (STTR) Phase I project will produce technology capable of constructing three-dimensional (3D) models of scenes accurately, rapidly, and at low cost. The technology leverages recent developments in computer vision and enhances them for operation under varying ambient conditions while increasing speed of model construction, thus enabling practical app ...

    STTR Phase I 2014 National Science Foundation
  5. STTR Phase I: 24x7 mobile wireless monitoring of patient's vitals to proactively manage disease recovery

    SBC: Argosy Omnimedia, Inc.            Topic: SH

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project is found in the proposed technology development that facilitates direct, ubiquitous acquisition of key biomedical data, with little or no human intervention or introduction of errors, has the potential to reduce the costs of healthcare and to revolutionize healthcare delivery throughout our so ...

    STTR Phase I 2014 National Science Foundation
  6. STTR Phase I: Sustainable Thermo-electric Conversion of Waste Heat

    SBC: IMPULSE TECHNOLOGY LLC            Topic: MI

    This Small Business Technology Transfer Phase I project will demonstrate and evaluate a novel film-based proof-of-concept Thermoelectric Energy Conversion (TEC) device. This research will advance the energy landscape through an innovative technology with a superior combination of efficiency, power density, and cost. TEC devices represent a zero emissions and zero operating cost technology. About 6 ...

    STTR Phase I 2014 National Science Foundation
  7. Development of VPL Vaccine for RSV

    SBC: SIGMOVIR BIOSYSTEMS, INC.            Topic: NIAID

    Project Summary Human respiratory syncytial virus (RSV) is recognized as the single most important viral cause of acute respiratory disease in infants and young children worldwide. Elderly populations and immunocompromised individuals are also at significant risk for serious RSV disease. Despite this very substantial disease burden imposed by RSV worldwide, there are no vaccines available. Severa ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Non-ATP competitive inhibitors of cyclin dependent kinases as cancer therapeutics

    SBC: PPI PHARMACEUTICALS, LLC            Topic: NCI

    DESCRIPTION (provided by applicant): As cancer is one of the leading causes of death in the United States with some sub-types remaining essentially untreatable, expansion of available drug targets will provide significant new options for the development ofmore effective antineoplastic agents. The major goal of this project is to apply a unique drug discovery strategy to cancer drug development. Th ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Rapid, Accurate, and Low-Cost Stool Clostridium difficile Genetic Test

    SBC: LENIMA FIELD DIAGNOSTICS LLC            Topic: NIAID

    DESCRIPTION (provided by applicant): Clostridium difficile (CD) is a bacterium causing diarrhea and other intestinal problems linked to 14,000 annual deaths in the US. CDI is an antibiotic-associated infection as well as a health-care-associated infection.Current CDI diagnosis relies on CD toxins enzyme immunoassay (EIA) together with antigen (GDH) EIA. Although stool toxin EIA is specific and rel ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Developing a Nrf2 activator for the treatment of scleroderma

    SBC: CUREVEDA, LLC            Topic: NIAMS

    DESCRIPTION (provided by applicant): Scleroderma is a devastating autoimmune disease with a chronic course, involving the overproduction of collagen leading to fibrosis of the skin and connective tissues. The disease has a range of symptoms including pain,stiffness and swelling of the joints, shortness of breath and gastrointestinal complications. More than 50% of patients with the aggressive form ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government